Selagine, Grifols agree to develop, commercialise immunoglobulin eye drops

Selagine has signed a research, development and sublicense agreement with Grifols for the development and commercialisation of immunoglobulin eye drops for dry eye disease.

Related Keywords

Grifols Deu ,Sandeep Jain ,National Institutes Of Health ,Office Of Technology Management ,Research To Prevent Blindness ,National Eye Institute ,Ui Health Pharmacy ,Department Of Ophthalmology ,University Of Illinois College Medicine ,University Of Illinois At Chicago ,Visual Sciences ,Illinois College ,National Institutes ,Prevent Blindness ,